Release Date: 28/04/20 08:23 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 701.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%